IMBDX (461030.KQ) Stock Price

IMBDX Price

CLOSED
2,850.00
​
Market closed

Over the last 4 years IMBDX grew revenue by 44.3% annually, reaching 5.33 B KRW. For IMBDX, the net margin of -148.9% is up versus -795.6% a few years ago.

IMBDX stock price

Access this data via the Eulerpool API

IMBDX business model & stock analysis

IMBDX Inc is a KR-based company operating in industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-04-03. IMBDX Inc is a Korea-based company principally engaged in the provision of laboratory analysis services. The firm is principally engaged in the provision of laboratory analysis services such as clinical diagnosis services and genetic analysis services based on liquid biopsy technology. In addition, the Company is also engaged in the development, manufacture and sale of diagnostic products.

Frequently asked questions about IMBDX

Converted at the current exchange rate, the IMBDX share trades at 1.89 EUR (2,850.00 KRW).

The expected revenue of IMBDX is 23.50 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of IMBDX is 415.06 M KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of IMBDX is currently 96.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the IMBDX stock.

The price-to-sales ratio (P/S) of IMBDX is currently 1.70. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the IMBDX stock.

The Eulerpool Quality Score for IMBDX is 3/10.

The ISIN of IMBDX is KR7461030009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of IMBDX is 461030.KQ. The ticker symbol is used to trade IMBDX shares on the stock exchange.

Fair ValueTerminal
2,907.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website imbdx.com
Country
South Korea
Currency
KRW
Initial public offering
Apr 3, 2024
ISIN
KR7461030009
Cusip
Y38860105
Market capitalization
38.16 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
91.94
P/S
P/Se
1.70
EV/EBIT
—
P/B Ratio
1.52
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-31.53 %
Last updated Oct 11, 2026, 9:27 AM

IMBDX Peer Group

All fundamentals and in-depth analysis of IMBDX

Our stock analysis for IMBDX stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IMBDX. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.